Endocrine pancreas: mechanisms of insulin secretion by the β-cells; interactions among insulin, glucagon and somatostatin

  • Barry J. Brass


The endocrine pancreas is composed of the islets of Langerhans which comprise approximately two million clusters of cells dispersed within the acinar tissue of the exocrine pancreas. In the adult, the islets constitute between one and two percent of the pancreatic mass. The islets are composed of four endocrine cell types: α-cells which secrete glucagon, β-cells which secrete insulin, δ-cells which secrete somatostatin, and PP cells which secrete pancreatic polypeptide (Table 1).


Insulin Secretion Secretory Vesicle Pituitary Adenylate Cyclase Activate Polypeptide Pancreatic Polypeptide Glucagon Secretion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Polonsky KS, Given, BD, Hirsch LJ, et al. Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus. N Engl J Med 318: 1231–1239, 1988.PubMedCrossRefGoogle Scholar
  2. 2.
    Polonsky KS, Given BD, and Van Cauter E. Twenty-four hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects. J Clin Invest 81: 442–448, 1988.PubMedCrossRefGoogle Scholar
  3. 3.
    Jaspan JB, Lever E, Polonsky KS, and Van Cauter E. In vivo pulsatility of pancreatic islet peptides. Am J Physiol 251:E215–226, 1986.Google Scholar
  4. 4.
    Newgard CB, and McGary JD. Metabolic coupling factors in pancreatic ß-cell signal transduction. Annu Rev Biochem 64: 689–719, 1995.PubMedCrossRefGoogle Scholar
  5. 5.
    Maechler P, and Wollheim, CB. Mitochondrial glutamate acts as a messenger in glucose-induced insulin exocytosis. Nature 402: 685–689, 1999.PubMedCrossRefGoogle Scholar
  6. 6.
    Bergman RN and Ader M. Free fatty acids and pathogenesis of type 2 diabetes mellitus. Trends Endocrinol Metab 11: 351–356, 2000.PubMedCrossRefGoogle Scholar
  7. 7.
    Dobbins RL, Chester MW, Daniels MB, et al. Circulating fatty acids are essential for efficient glucose-stimulated insulin secretion after prolonged fasting in humans. Diabetes 47: 1613–1618, 1998.PubMedCrossRefGoogle Scholar
  8. 8.
    Carpentier A, Mittelman SD, Lamarche B, et al. Acute enhancement of insulin secretion by FFA in humans is lost with prolonged FFA elevation. Am J Physiol 276: E1055–1066, 1999.PubMedGoogle Scholar
  9. 9.
    Ahren B. Autonomic regulation of islet hormone secretion–implications for health and disease. Diabetologia 43: 393–410, 2000.PubMedCrossRefGoogle Scholar
  10. 10.
    Schmitz-Peiffer C. Signaling aspects of insulin resistance in skeletal muscle: mechanisms induced by lipid oversupply. Cellular Signal 12: 583–594, 2000.CrossRefGoogle Scholar
  11. 11.
    Poitout V and Robertson RP. An integrated view of ß-cell dysfunction in type 2 diabetes. Annu Rev Med 47: 69–83, 1996.PubMedCrossRefGoogle Scholar
  12. 12.
    Aryan P, and Castle D. Sorting and storage during secretory granule biogenesis: looking backward and looking forward. Biochem J 332: 593–610, 1998.Google Scholar
  13. 13.
    Liang Y, Matschinsky FM. Mechanisms of action of nonglucose insulin secretagogues. Annu Rev Nutr 14: 59–81, 1994.PubMedCrossRefGoogle Scholar
  14. 14.
    Edwards CM, Todd JF, and Mahmoudi M. Glucagon-like peptide 1 has a physiological role in the control of postprandial glucose in humans: studies with the antagonist exendin 9–39. Diabetes 48: 86–93, 1999.PubMedCrossRefGoogle Scholar
  15. 15.
    Carroll RJ, Hammer RE, Chan SJ, et al. A mutant human proinsulin is secreted from islets of Langerhans in increased amounts via an unregulated pathway. Proc Natl Acad Sci USA 85: 8943–8947, 1988.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2004

Authors and Affiliations

  • Barry J. Brass

There are no affiliations available

Personalised recommendations